CytomX Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
Morning Call For Wednesday, October 4
Article By: Jim Van Meerten
Wednesday, October 4, 2017 10:17 AM EDT
Dec E-mini S&Ps (ESZ17 -0.02%) this morning are down -0.09% and European stocks are down -0.56% as weakness in crude oil drags energy stocks lower.
In this article: KHC, LEN, WGO, JACK, TSLA, GBT, CTMX, NLNK, ODP, I, RIGL
Read
Premarket Biotech Digest – PFE Receives EU Approval, ALKS Announces Positive Results, SRNE Receives FDA Approval
Article By: KKD Healthcare Analytics
Friday, June 30, 2017 9:30 AM EDT
Pfizer Inc. announced receiving the European Commission’s approval for Besponsa treatment for adults with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia.
In this article: MYOV, PFE, ALKS, SRNE, EIGR, WBA, LH, CTMX
Read
All Posts

Latest Tweets for $CTMX

No tweets yet!

PARTNER HEADLINES